2 No-Brainer Healthcare Stocks to Buy Right Now
Investors looking to participate in the stock market have a multitude of options, and it can sometimes be hard to separate the wheat from the chaff. But some companies look especially attractive, perhaps due to reasonable valuations, excellent prospects, or other factors.
Buying shares of such businesses and holding onto them for a while is one of the secrets to earning outsize returns over the long run. Let's examine two healthcare stocks that look like excellent picks right now: (NYSE: ABBV) and Veeva Systems (NYSE: VEEV).
Pharmaceutical giant AbbVie isn't doing well in the stock market in 2023 thus far, and the reason behind that is no secret. The company lost U.S. patent exclusivity for its blockbuster drug Humira earlier this year. Biosimilar competition is already eating into the market share of the rheumatoid arthritis medicine. Due to this major patent cliff, AbbVie's sales will continue to decline until next year.
Source Fool.com
AbbVie Inc. Aktie
Die AbbVie Inc. Aktie genießt uneingeschränkte Beliebtheit: Nur Buy-Einschätzungen.
Ein Kursziel von 180 € für AbbVie Inc. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 174.48 €.
